Translated from German: From the sunny highlands of Jamaica to German pharmacies – Cantourage and Cannim bring medical HummingBud cannabis flower to Germany. Cantourage and Cannim are deepening their partnership and – starting today – are expanding the treatment options for patients in Germany with the highly potent Sativa-dominant genetic “Wild Thailand”....
Press Release Cannim launches Jamaican cannabis flower to the Australian medicinal market Cannim, an Australian-based producer of premium medicinal cannabis, has announced that its Jamaican cannabis flower is now available to Australian patients under the Special Access Scheme. Cannim’s Chief Commercial Officer, Stuart Marsh said that the product, which is being sold as high-THC dried...
Apple has recently made a decision to allow cannabis-centred apps on the app store. The new policy states that “licensed and otherwise legal cannabis dispensaries” are now able to work with Apple. This decision will potentially have an impact on the doctor-patient relationship, assisting doctors in finding the right dosages, as well as tracking effects...
Banking politics are stifling Jamaica’s unique opportunity to foster a medicinal cannabis industry. It’s reassuring to see senior members of the Jamaican government engaging with the industry to actively find solutions to these significant problems. Full article link here
With the demand for CBD so high, sub-par products have been flooding the market. It is incredibly important to source from businesses with stringent testing around growing and manufacturing. Full article hereÂ
Given the popularity of CBD, biotech firms are attempting to synthesis CBD to meet expanding demand. Synthesised CBD would lack the entourage effect of natural CBD, so it will be interesting to see how the efficacy of these alternatives stacks up. Full article link here
With 25% of 192 million people polled across three countries stating that their use is partly medicinal. The market segment of medical cannabis is in for a surge of demand and we are prepared to meet that opportunity. See full article here
The potential for over-the-counter CBD access in Australia has led to questions surrounding the maximum doses permitted. The Lamber Initiative shows that 60 milligrams a day may not be high enough to benefit patients. However, this still creates an opportunity for Cannim to offer Australians the relief they need and remains a space to watch...
The potential for over-the-counter CBD access in Australia has led to questions surrounding the maximum doses permitted. The Lamber Initiative shows that 60 milligrams a day may not be high enough to benefit patients. However, this still creates an opportunity for Cannim to offer Australians the relief they need and remains a space to watch....
2017 marked the 25th anniversary of one of the most important discoveries in cannabinoid science. On March 24, 1992, LumÃr HanuÅ¡, a Czech analytical chemist working in Israel with American pharmacologist William Devane, isolated the first known endocannabinoid in the human brain. They named it anandamide, after the Sanskrit word for joy or bliss. Link...
